AKT1 and breast carcinoma: Furthermore, we observed in this study that MCF-7 and ZR-75-1 breast cancer cell lines resistant to endocrine therapy exhibited higher levels of p-AKT compared to sensitive cells, in line with previous findings of a significant increase in p-AKT and high AKT kinase activity in antiestrogen-resistant cell lines41.